Search research articles
Contact Us
Filters
Showing results (221-230 of 230) with videos related to
Page
of 23
Sort By:
You have reached the last page of results.
This site can display upto 230 results.
Genes, Chromosomes & Cancer
|
August 5, 2000
MLL amplification in myeloid leukemias: A study of 14 cases with multiple copies of 11q23
L Michaux, I Wlodarska, M Stul, et al.
Leukemia
|
May 1, 1997
Characteristic pattern of chromosomal gains and losses in marginal zone B cell lymphoma detected by comparative genomic hybridization
J Dierlamm, C Rosenberg, M Stul, et al.
Leukemia
|
April 17, 2022
The complex karyotype in hematological malignancies: a comprehensive overview by the Francophone Group of Hematological Cytogenetics (GFCH)
F Nguyen-Khac, A Bidet, A Daudignon, et al.
Cancer Genetics and Cytogenetics
|
June 19, 2007
Fluorescence in situ hybridization analysis of 110 hematopoietic disorders with chromosome 5 abnormalities: do de novo and therapy-related myelodysplastic syndrome-acute myeloid leukemia actually differ?
M Lessard, C Hélias, S Struski, et al.
Nature Genetics
|
September 14, 2004
Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia
C Graux, J Cools, C Melotte, et al.
Leukemia
|
October 17, 2008
Heterogeneous patterns of amplification of the NUP214-ABL1 fusion gene in T-cell acute lymphoblastic leukemia
C Graux, M Stevens-Kroef, M Lafage, et al.
Leukemia
|
May 15, 2007
A comprehensive genetic and histopathologic analysis identifies two subgroups of B-cell malignancies carrying a t(14;19)(q32;q13) or variant BCL3-translocation
J I Martín-Subero, R Ibbotson, W Klapper, et al.
Leukemia
|
September 13, 2003
t(5;14)/HOX11L2-positive T-cell acute lymphoblastic leukemia. A collaborative study of the Groupe Français de Cytogénétique Hématologique (GFCH)
R Berger, N Dastugue, M Busson, et al.
Leukemia
|
February 6, 2020
Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS
G J Ossenkoppele, D A Breems, G Stuessi, et al.
Leukemia
|
August 1, 2020
Correction: Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS
G J Ossenkoppele, D A Breems, G Stuessi, et al.
Page
of 23
Search research articles
Search
Showing results (221-230 of 230) with videos related to
Sort By:
Page
of 23
You have reached the last page of results.
This site can display upto 230 results.
Genes, Chromosomes & Cancer
|
August 5, 2000
MLL amplification in myeloid leukemias: A study of 14 cases with multiple copies of 11q23
L Michaux, I Wlodarska, M Stul, et al.
Leukemia
|
May 1, 1997
Characteristic pattern of chromosomal gains and losses in marginal zone B cell lymphoma detected by comparative genomic hybridization
J Dierlamm, C Rosenberg, M Stul, et al.
Leukemia
|
April 17, 2022
The complex karyotype in hematological malignancies: a comprehensive overview by the Francophone Group of Hematological Cytogenetics (GFCH)
F Nguyen-Khac, A Bidet, A Daudignon, et al.
Cancer Genetics and Cytogenetics
|
June 19, 2007
Fluorescence in situ hybridization analysis of 110 hematopoietic disorders with chromosome 5 abnormalities: do de novo and therapy-related myelodysplastic syndrome-acute myeloid leukemia actually differ?
M Lessard, C Hélias, S Struski, et al.
Nature Genetics
|
September 14, 2004
Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia
C Graux, J Cools, C Melotte, et al.
Leukemia
|
October 17, 2008
Heterogeneous patterns of amplification of the NUP214-ABL1 fusion gene in T-cell acute lymphoblastic leukemia
C Graux, M Stevens-Kroef, M Lafage, et al.
Leukemia
|
May 15, 2007
A comprehensive genetic and histopathologic analysis identifies two subgroups of B-cell malignancies carrying a t(14;19)(q32;q13) or variant BCL3-translocation
J I Martín-Subero, R Ibbotson, W Klapper, et al.
Leukemia
|
September 13, 2003
t(5;14)/HOX11L2-positive T-cell acute lymphoblastic leukemia. A collaborative study of the Groupe Français de Cytogénétique Hématologique (GFCH)
R Berger, N Dastugue, M Busson, et al.
Leukemia
|
February 6, 2020
Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS
G J Ossenkoppele, D A Breems, G Stuessi, et al.
Leukemia
|
August 1, 2020
Correction: Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS
G J Ossenkoppele, D A Breems, G Stuessi, et al.
Page
of 23